Anticoagulation for hypercoagulability in severe critical COVID-19: A case series of fading and fatal cycles of microthrombosis

The pathophysiology of the COVID-19 involves a systemic hypercoagulable state and systemic micro-thrombosis which can cause fatal consequences. Despite that anticoagulation seems an intuitive therapeutic option, the US National Institute of Health has issued a warning against its use in critically i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ronderos Botero, Diana Maria, Omar, Alaa Mabrouk Salem, Nicu, Marin, Sklyar, Eduard, Bella, Jonathan N., Chilimuri, Sridhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese College of Cardiology 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450317/
https://www.ncbi.nlm.nih.gov/pubmed/34567288
http://dx.doi.org/10.1016/j.jccase.2021.08.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450317/
https://www.ncbi.nlm.nih.gov/pubmed/34567288
http://dx.doi.org/10.1016/j.jccase.2021.08.013

Ejemplares similares